Application to Present Deadline for Invest Northwest 2008 is December 7, 2007

SEATTLE – Nov. 28, 2007 – Life sciences companies from Washington, Oregon, Montana, Idaho, British Columbia and Alberta are encouraged to submit their applications to present at the seventh annual CEO and Investor conference, Invest Northwest™, organized by the Washington Biotechnology and Biomedical Association. Submissions will be accepted no later than December 7, 2007. Invest Northwest will be held March 18-19, 2008 in Seattle, Washington.

Applications to Present and details on eligibility are online at http://www.investnorthwest.org/

Invest Northwest is a forum for senior executives from Northwest public and private life science companies to tell their stories to institutional investors, analysts, investment bankers, fund managers, venture capitalists, angel investors and prospective corporate partners. Produced by the Washington Biotechnology & Biomedical Association in collaboration with BC Biotech, BC Medtech, BioAlberta, BioIdaho, Montana BioScience Alliance and the Oregon Bioscience Association, the yearly event typically attracts more than 600 attendees.

Members of the professional investment community and bioscience leaders are invited to register to attend at www.investnorthwest.org or call WBBA for more information at 206.732.6700.

Platinum Partner Sponsor of WBBA’s Invest Northwest 2008 is Moss Adams LLP.

About the Washington Biotechnology & Biomedical Association Based in Seattle, the Washington Biotechnology & Biomedical Association (WBBA) is a not-for-profit association of Washington state-based biotechnology and medical device companies, research institutions and related organizations working together to extend better health to people everywhere. For more information about WBBA, visit www.wabio.com. To register for events, visit www.washbio.org.